Reassessment of Alzheimer’s Drug Raises Hope—and Concerns
Will the benefits of aducanumab be enough to justify FDA approval, given its small benefit and high price?
Latest Stories
Can a Big Oil Company Go Carbon-Free?
Spanish oil giant Repsol SA this week announced one of the more ambitious emissions reduction efforts in the industry
What’s Shaking in Oklahoma?
Mysterious seismic signals lead to some scientific detective work
3 Problems with High-Intensity Interval Training
The allure of short, intense workouts is obvious. But is High-Intensity Interval Training (HIIT) really the only workout you need for good overall fitness?
How a Flawed Experiment “Proved” That Free Will Doesn’t Exist
It did no such thing—but the result has become conventional wisdom nevertheless
Fishy Trick Lures Life Back to Coral Reefs
Playing the sounds of a healthy reef near damaged corals may help bring the fish community back. Christopher Intagliata reports.
A Tiny Leak Led to a Massive, Unexpected Collapse at Kilauea Volcano
Its caldera’s dramatic, surprisingly slow collapse could point to other risks worldwide
Now Hear This: New Fossils Reveal Early Ear-Bone Evolution
A change in chewing led to the emergence of the mammalian middle ear
Climate Models Got It Right on Global Warming
Even models in the 1970s accurately predicted the relationship between greenhouse gas emissions and temperature rise
The Language You Speak Influences Where Your Attention Goes
It’s all because of the similarities between words
